We also found out that CDK8 specific siRNA inhibited the proliferation of colon cancer cells, promoted their apoptosis and arrested these cells in the G0/G1 phase. In addition, CDK8 inhibition may be associated with the down-regulation of β-catenin. Our results
showed that CDK8 and β-catenin could be promising target in the regulation of colon cancer by the control of β-catenin through CDK8. Acknowledgements AZD5582 purchase This work was supported by natural science research grants in University of Jiangsu Province, China (No.09KJD320005), grants from Medical Science and Technology Development Foundation, Jiangsu Province Department of Health, China (No.H201013), Program for Postgraduate Research Innovation in University of Jiangsu Province, China ON-01910 (No.CX10B_054Z), and Project of Youth Foundation in Science and Education of Department of Public Health of Suzhou, China (No.SWKQ1004). References 1. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D: Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009,9(7):489–99.PubMedCrossRef 2. Bienz M, Clevers H: Linking colorectal cancer to Wnt signaling. Cell 2000, 103:311–320.PubMedCrossRef 3. Firestein R, Hahn WC: Revving the Throttle on
an oncogene: CDK8 takes the driver seat. Cancer Res 2009, 69:7899–7901.PubMedCrossRef 4. Tetsu O, McCormick F: Beta-catenin regulates expression of cyelin D1 in colon carcinoma cells. Nature 1999,398(6726):422–6.PubMedCrossRef 5. Kim S, Xu X, Hecht A, Boyer TG: Mediator is a transducer of Wnt/beta-catenin signaling. J Biol Chem 2006, 281:14066–14075.PubMedCrossRef 6. Conaway RC, Sato S, Tomomori-Sato C, Yao T, Conaway JW:
The mammalian Mediator complex and its role in transcriptional regulation. Trends check details Biochem Sci 2005,30(5):250–5.PubMedCrossRef 7. Mouriaux F, Casagrande F, Pillaire MJ, Manenti S, Malecaze F, Darbon JM: Differential expression of G 1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed Anacetrapib melanocytes. Invest Ophthalmol Vis Sci 1998,39(6):876–88.PubMed 8. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS, Loda M, Shivdasani RA, Meyerson M, Hahn WC: CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 2008,455(7212):547–51.PubMedCrossRef 9. Morris EJ, Ji JY, Yang F, Di Stefano L, Herr A, Moon NS, Kwon EJ, Haigis KM, Naar AM, Dyson NJ: E2F1 represses beta-catenin transcription and is antagonized by both Prb and CDK8. Nature 2008, 455:552–6.PubMedCrossRef 10. Malik S, Roeder RG: Dynamic regulation of pol II transcription by themammalian Mediator complex. Trends Biochem Sci 2005,30(5):256–63.PubMedCrossRef 11.